<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Angarita-Rodriguez A</submitter><funding>Pontificia Universidad Javeriana</funding><pagination>648</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11124372</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(5)</volume><pubmed_abstract>Astrocytes play a pivotal role in maintaining brain homeostasis. Recent research has highlighted the significance of palmitic acid (PA) in triggering pro-inflammatory pathways contributing to neurotoxicity. Furthermore, Genomic-scale metabolic models and control theory have revealed that metabolic switches (MSs) are metabolic pathway regulators by potentially exacerbating neurotoxicity, thereby offering promising therapeutic targets. Herein, we characterized these enzymatic MSs in silico as potential therapeutic targets, employing protein-protein and drug-protein interaction networks alongside structural characterization techniques. Our findings indicate that five MSs (P00558, P04406, Q08426, P09110, and O76062) were functionally linked to nervous system drug targets and may be indirectly </pubmed_abstract><journal>Pharmaceuticals (Basel, Switzerland)</journal><pubmed_title>Enzymatic Metabolic Switches of Astrocyte Response to Lipotoxicity as Potential Therapeutic Targets for Nervous System Diseases.</pubmed_title><pmcid>PMC11124372</pmcid><funding_grant_id>BPIN2020000100357</funding_grant_id><pubmed_authors>Matiz-Gonzalez JM</pubmed_authors><pubmed_authors>Aristizabal AF</pubmed_authors><pubmed_authors>Barreto GE</pubmed_authors><pubmed_authors>Gonzalez J</pubmed_authors><pubmed_authors>Ramirez D</pubmed_authors><pubmed_authors>Pinzon A</pubmed_authors><pubmed_authors>Angarita-Rodriguez A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enzymatic Metabolic Switches of Astrocyte Response to Lipotoxicity as Potential Therapeutic Targets for Nervous System Diseases.</name><description>Astrocytes play a pivotal role in maintaining brain homeostasis. Recent research has highlighted the significance of palmitic acid (PA) in triggering pro-inflammatory pathways contributing to neurotoxicity. Furthermore, Genomic-scale metabolic models and control theory have revealed that metabolic switches (MSs) are metabolic pathway regulators by potentially exacerbating neurotoxicity, thereby offering promising therapeutic targets. Herein, we characterized these enzymatic MSs in silico as potential therapeutic targets, employing protein-protein and drug-protein interaction networks alongside structural characterization techniques. Our findings indicate that five MSs (P00558, P04406, Q08426, P09110, and O76062) were functionally linked to nervous system drug targets and may be indirectly </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-05-27T12:13:19.8Z</modification><creation>2026-05-27T03:12:09.49Z</creation></dates><accession>S-EPMC11124372</accession><cross_references><pubmed>38794218</pubmed><doi>10.3390/ph17050648</doi></cross_references></HashMap>